Physician profile
Stephen Blake Wallace
NPI 1205222502
$32,504.77
in general payments reported to CMS, 2019-2025
20 companies · $4,075 in 2025
The $4,075 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,053 · 2020: $10K · 2021: $5,460 · 2022: $3,708 · 2023: $4,807 · 2024: $1,401 · 2025: $4,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,500 · Food and Beverage: $2,759 · Travel and Lodging: $2,023.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,500.00 |
| Food and Beverage | $2,759.28 |
| Travel and Lodging | $2,023.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $18,530.95 | 2019-2025 | |
| Pylant Medical | $5,231.27 | 2019-2025 | |
| Extremity Medical | $4,757.38 | 2021-2025 | Io Freedom |
| Stryker Corporation | $1,116.16 | 2021-2025 | Infinity, Axs Infinity Ls, Augment Injectable |
| Vilex LLC | $1,000.00 | 2024-2025 | Fuze |
| Paragon 28, INC. | $369.05 | 2021-2023 | Monkey Rings |
| Linvatec Corporation | $238.29 | 2024-2025 | Quantum, Biobrace 23mm |
| Medical Device Business Services, INC. | $229.97 | 2021 | |
| Depuy Synthes Sales INC. | $229.04 | 2021-2025 | Na, Monovisc, Orthovisc |
| Restor3d, INC. | $207.43 | 2024 | |
| Si-Bone, INC. | $126.48 | 2024 | |
| Next Science LLC | $90.39 | 2024 | Xperience, Surgx, Blastx |
| Bioventus LLC | $86.22 | 2025 | Exogen Ultrasound Bone Healing System |
| Medline Industries LP | $73.50 | 2021-2022 | |
| Orthalign INC | $73.19 | 2024 | Orthalign Plus |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $43.45 | 2024 | Harvest |
| Smith+Nephew, INC. | $43.00 | 2021-2023 | Cadence |
| Innovation Technologies INC | $21.37 | 2024 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $18.89 | 2025 | Exparel |
| Axogen | $18.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.